Comment
doi: 10.1007/BF01704712.
Determination of the optimum timing for pharmacokinetic monitoring of once daily aminoglycoside dosing
- PMID: 8014297
- DOI: 10.1007/BF01704712
Item in Clipboard
Comment
Determination of the optimum timing for pharmacokinetic monitoring of once daily aminoglycoside dosing
Intensive Care Med.
1994.
No abstract available
Comment on
-
Studies on drug monitoring in thrice and once daily treatment with aminoglycosides.Intensive Care Med. 1993;19(4):215-20. doi: 10.1007/BF01694773. Intensive Care Med. 1993. PMID: 8366230
Similar articles
-
Commentary: once-daily aminoglycoside dosing: where are we now?J Crit Care. 2003 Jun;18(2):113-4. doi: 10.1053/jcrc.2003.50007. J Crit Care. 2003. PMID: 12800121 No abstract available.
-
[Aminoglycoside antibiotics].Nihon Rinsho. 2004 Dec;62 Suppl 12:427-31. Nihon Rinsho. 2004. PMID: 15658355 Review. Japanese. No abstract available.
-
Intravenous aminoglycoside usage and monitoring of patients with cystic fibrosis in Australia. What's new?Intern Med J. 2009 Aug;39(8):527-31. doi: 10.1111/j.1445-5994.2008.01787.x. Epub 2008 Aug 16. Intern Med J. 2009. PMID: 19220547
-
Therapeutic drug monitoring of aminoglycosides in neonates.Clin Pharmacokinet. 2009;48(2):71-88. doi: 10.2165/00003088-200948020-00001. Clin Pharmacokinet. 2009. PMID: 19271781 Review.
-
Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.Pharmacotherapy. 2010 Jan;30(1):95-108. doi: 10.1592/phco.30.1.95. Pharmacotherapy. 2010. PMID: 20030477 Review.